Guardant Current Deferred Revenue from 2010 to 2026
| GH Stock | USD 107.38 0.04 0.04% |
Current Deferred Revenue | First Reported 2017-12-31 | Previous Quarter 54.4 M | Current Value 46.9 M | Quarterly Volatility 12.3 M |
Check Guardant Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Guardant Health's main balance sheet or income statement drivers, such as Tax Provision of 1.6 M, Net Interest Income of 61.7 M or Interest Income of 64.8 M, as well as many indicators such as Price To Sales Ratio of 5.54, Dividend Yield of 0.0 or Days Sales Outstanding of 88.45. Guardant financial statements analysis is a perfect complement when working with Guardant Health Valuation or Volatility modules.
Guardant | Current Deferred Revenue | Build AI portfolio with Guardant Stock |
The Current Deferred Revenue trend for Guardant Health offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Guardant Health is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Guardant Health's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Guardant Health over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Guardant Health's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Guardant Health's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Guardant Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 12,890,695 | |
| Geometric Mean | 6,671,124 | |
| Coefficient Of Variation | 109.78 | |
| Mean Deviation | 10,970,076 | |
| Median | 8,550,000 | |
| Standard Deviation | 14,151,025 | |
| Sample Variance | 200.3T | |
| Range | 40.9M | |
| R-Value | 0.87 | |
| Mean Square Error | 52.1T | |
| R-Squared | 0.76 | |
| Slope | 2,436,753 | |
| Total Sum of Squares | 3204T |
Guardant Current Deferred Revenue History
About Guardant Health Financial Statements
Investors use fundamental indicators, such as Guardant Health's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Guardant Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 40.8 M | 42.8 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Guardant Health Correlation against competitors. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is there potential for Health Care Providers & Services market expansion? Will Guardant introduce new products? Factors like these will boost the valuation of Guardant Health. Market participants price Guardant higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.22) | Revenue Per Share | Quarterly Revenue Growth 0.385 | Return On Assets | Return On Equity |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Guardant Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.